Another GSK dosing denial
July 19, 2013
GLAXOSMITHKLINE’S Children’s
Panadol 1-5 years suspension
remains in limbo, after the Federal
Court this week granted another
temporary injunction against an
alternative dosing system.
GSK was forced to remove the
product from pharmacy shelves
some weeks ago, after rival Reckitt
Benckiser brought a case against
the company alleging that the
syringe-based dispenser used on
the Panadol product infringed a
patent on RB’s dosing system for
Nurofen for Children (PD 07 Jun).
In this latest development, a
decision rendered on Wednesday
granted the injunction against an
alternative syringe-based dosing
device for use with the new
Children’s Panadol 1-5 years.
GSK said it’s now “considering
its options” pending final court
hearings over the matters.
The company noted that the
legal proceedings relate only to
the new Children’s Panadol 1-5
years suspension, with Children’s
Panadol Baby Drops, Children’s
Panadol 5-12 years Elixir and the
new Children’s Panadol 5-12 years
suspensions not impacted.
GSK reassured customers that
there is no safety risk associated
with the new Children’s Panadol
range, adding that it’s “using
its best endeavours to ensure
Childrens Panadol 1-5 years
suspension product will be
available to customers as soon as
possible”.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Jul 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Jul 13
Warning: Undefined variable $flipbook_id in
/home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line
1259
Warning: Undefined variable $o_shortcode_atts in
/home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line
1263
Warning: Undefined variable $output in
/home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line
1266
